Robert Olstein Olstein Capital Management
Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAL
Ralliant Corp
RAL
|
+$5.24M |
| 2 |
Constellation Brands
STZ
|
+$4.53M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$3.8M |
| 4 |
LKQ Corp
LKQ
|
+$3M |
| 5 |
Amazon
AMZN
|
+$2.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eastman Chemical
EMN
|
+$5.53M |
| 2 |
WCC
WESCO International
WCC
|
+$5.19M |
| 3 |
Corning
GLW
|
+$3.5M |
| 4 |
L3Harris
LHX
|
+$3.39M |
| 5 |
Aptiv
APTV
|
+$3.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.94% |
| 2 | Technology | 18.3% |
| 3 | Healthcare | 17.68% |
| 4 | Financials | 14.49% |
| 5 | Consumer Discretionary | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Walt Disney
DIS
$186B
| $12.5M | 2.36% |
109,000
-3,000
| -3% | -$353K |
|
2
Vontier
VNT
$4.46B
| $10.7M | 2.03% |
256,000
-39,000
| -13% | -$1.61M |
|
3
Sensata Technologies
ST
$6.23B
| $10.6M | 2% |
346,000
-21,000
| -6% | -$663K |
|
4
Avantor
AVTR
$9.78B
| $9.91M | 1.87% |
794,000
+115,000
| +17% | +$1.48M |
|
5
Becton Dickinson
BDX
$52.3B
| $9.73M | 1.84% |
52,000
+1,000
| +2% | +$186K |
|
|
6
LKQ Corp
LKQ
$6.52B
| $9.72M | 1.84% |
318,266
+91,266
| +40% | +$3M |
|
7
ABM Industries
ABM
$2.74B
| $9.64M | 1.82% |
208,972
-3,000
| -1% | -$142K |
|
8
Johnson & Johnson
JNJ
$651B
| $8.99M | 1.7% |
48,500
-12,500
| -20% | -$2.14M |
|
9
Omnicom Group
OMC
$24B
| $8.97M | 1.69% |
110,000
| – | – |
|
10
SLB Ltd
SLB
$79.9B
| $8.7M | 1.64% |
253,000
| – | – |
|
11
Baxter International
BAX
$13.6B
| $8.31M | 1.57% |
365,000
+96,000
| +36% | +$2.43M |
|
12
Medtronic
MDT
$119B
| $8.29M | 1.56% |
87,000
+3,000
| +4% | +$276K |
|
13
Reynolds Consumer Products
REYN
$5.37B
| $7.97M | 1.5% |
325,550
+3,550
| +1% | +$80.3K |
|
14
General Dynamics
GD
$104B
| $7.94M | 1.5% |
23,290
-7,710
| -25% | -$2.43M |
|
15
Citizens Financial Group
CFG
$29.4B
| $7.77M | 1.47% |
146,146
-43,054
| -23% | -$2.14M |
|
16
International Flavors & Fragrances
IFF
$21.5B
| $7.69M | 1.45% |
125,000
+20,000
| +19% | +$1.37M |
|
17
Zimmer Biomet
ZBH
$19.3B
| $7.68M | 1.45% |
78,000
| – | – |
|
18
Dine Brands
DIN
$454M
| $7.68M | 1.45% |
310,711
+54,711
| +21% | +$1.28M |
|
|
19
Aptiv
APTV
$10B
| $7.63M | 1.44% |
88,449
-40,551
| -31% | -$3.06M |
|
|
HOLX
20
DELISTED
Hologic
HOLX
| $7.63M | 1.44% |
113,000
-2,000
| -2% | -$133K |
|
21
Quest Diagnostics
DGX
$27B
| $7.62M | 1.44% |
40,000
| – | – |
|
22
Delta Air Lines
DAL
$54.2B
| $7.61M | 1.44% |
134,000
-30,000
| -18% | -$1.71M |
|
23
US Bancorp
USB
$96.7B
| $7.61M | 1.44% |
157,348
-11,652
| -7% | -$551K |
|
24
Middleby
MIDD
$5.22B
| $7.58M | 1.43% |
57,000
+14,538
| +34% | +$2.02M |
|
25
Kulicke & Soffa
KLIC
$4.49B
| $7.56M | 1.43% |
186,000
| – | – |
|
Similar funds
Robert Olstein's Q3 2025 Portfolio in Review
As of Q3 2025, Robert Olstein held 105 positions worth $530M, down 0.71% from $533M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Robert Olstein withdrew a net $23.2M in Q3 2025, closing 2 positions and reducing 51 holdings. Its most notable exit was Eastman Chemical, an estimated $5.53M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Robert Olstein opened a new position in Constellation Brands worth $3.84M.
- Robert Olstein's largest Q3 2025 buy was Constellation Brands: 28,500 shares worth $3.84M.
- Robert Olstein added most to Ralliant Corp in Q3 2025, an estimated $5.24M increase.
- Robert Olstein's biggest Q3 2025 reduction was WESCO International, cutting an estimated $5.19M.
- Robert Olstein fully exited Eastman Chemical in Q3 2025, selling an estimated $5.53M.
- Robert Olstein's ten largest holdings make up 19% of its $530M portfolio in Q3 2025.
- Robert Olstein opened 4 new positions and closed 2 in Q3 2025.
- Robert Olstein's portfolio value fell 0.71% quarter-over-quarter to $530M.
Based on Olstein Capital Management's 13F filing for Q3 2025, filed 21 Oct 2025.